🔥Recent advances in #neuroimaging of #Alzheimers disease 🧠✨

dx.doi.org/10.1002/alz....

➡️ Valuable resource for both researchers & clinicians!
➡️ ATNIV biomarkers, staging, connectomics & more
➡️ Plus: how are sex & country represented in first/last authorship?

@istaart.bsky.social Neuroimaging PIA

🎙️ Plasma biomarkers, PET, and MRI – @alexapb.bsky.social explains how these tools are reshaping Alzheimer’s diagnostics in the @istaart.bsky.social Neuroimaging PIA. Listen now or Watch the last episode in this series.

Watch: youtu.be/x2ifaepExB0
Listen: pod.fo/e/2fde7c

I strongly support the NIH Diversity Supplement Program. Addressing the severe lack of diversity among biomedical researchers improves the quality of research. It's not a level playing field. This program helps restore equity through mentored training. Rescinding this program is a big mistake

www.nature.com/articles/d41...
I’ve been trying to not get worked up with every crazy thing that has happened with the election, but this is likely something to worry about. Really shows how an unserious person Trump is.

Are my kids the only ones who find the winter solstice the IDEAL time to play with water balloons?

New preprint out: using data from DIAN, we estimate what sample sizes would be needed for various biomarker outcomes in clinical trials of autosomal dominant Alzheimer's disease: www.medrxiv.org/content/10.1...